An Open-Label Study to Evaluate the Absolute Bioavailability of Intranasal and Oral Esketamine and the Effects of Clarithromycin on the Pharmacokinetics of Intranasal Esketamine in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2015
At a glance
- Drugs Esketamine (Primary) ; Esketamine (Primary) ; Esketamine (Primary) ; Clarithromycin
- Indications Major depressive disorder
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Janssen Research & Development
- 25 Sep 2015 Status changed from recruiting to completed ClinicalTrials.gov.
- 10 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 23 Jan 2015 New trial record